-
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy
van der Schans, J. J., Vishwasrao, P., Poels, R., Antti, M., Wang, Z., Quik, M., van Arkel, J., Reuvekamp, T., van de Donk, N. W. C. J., Themeli, M., Ossenkoppele, G. J., van de Loosdrecht, A. A., Richards, R. & Mutis, T., 1 Jul 2025, In: HemaSphere. 9, 7, e70155.Research output: Contribution to journal › Article* › Academic › peer-review
-
Different features of acute myeloid leukemia stem cell quantification in intensively treated patients
Ngai, L. L., Reuvekamp, T., Hanekamp, D., Janssen, F., Marsbergen, L.O.-V., Carbaat-Ham, J., Hofland, M. A. M., Fayed, M. M. H. E., Kelder, A., Snel, A. N., Bachas, C., Tettero, J. M., Breems, D. A., Fischer, T., Gjertsen, B. T., Griškevičius, L., Juliusson, G., Van de Loosdrecht, A. A., Maertens, J. A. & Manz, M. G. & 9 others, , 30 Apr 2025, (E-pub ahead of print) In: Haematologica.Research output: Contribution to journal › Article* › Academic › peer-review
-
CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents: ACUTE MYELOID LEUKEMIA
Reuvekamp, T., Ngai, L. L., den Hartog, D., Carbaat-Ham, J., Fayed, M. M. H. E., Scholten, W. J., Mocking, T. R., Chitu, D. A., Pabst, T., Klein, S. K., Stussi, G., Griskevicius, L., Breems, D., van Lammeren-Venema, D., Boersma, R., Ossenkoppele, G. J., van de Loosdrecht, A. A., Bachas, C., Huls, G. A. & de Leeuw, D. C. & 1 others, , Apr 2025, In: Leukemia. 39, 4, p. 972-975 4 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
